Robert Fisher, MD
Urology · Rockport, MENPI 1043746068
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,126 of the $9,242 with a category attached, or 66.3%. It is spread thinly across 26 manufacturers, the largest accounting for just 21.4%. Among urology clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $60.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Teleflex LLC$2K
- Boston Scientific$2K
- Axonics, Inc.$2K
- Procept Biorobotics Corporation$814
- Angiodynamics, Inc.$212
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$2953%
- Grants$2963%
- Travel & lodging$2,52527%
- Food & beverage$6,12666%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 15 | $1,980 |
| Teleflex LLC | 19 | $1,803 |
| Boston Scientific | 27 | $1,692 |
| Axonics, Inc. | 23 | $1,592 |
| Procept Biorobotics Corporation | 14 | $814 |
| Angiodynamics, Inc. | 5 | $212 |
| Sumitomo Pharma America, Inc. | 8 | $177 |
| Ambu Inc. | 2 | $168 |
| Endo Pharmaceuticals Inc. | 8 | $146 |
| Intuitive Surgical | 3 | $106 |
| ABC Home Medical Supply, Inc. | 4 | $85 |
| Coloplast | 4 | $67 |
| Astellas Pharma US Inc | 3 | $53 |
| Myovant Sciences Inc. | 2 | $48 |
| Antares Pharma, Inc. | 3 | $45 |
| Myriad Genetic Laboratories, Inc. | 2 | $40 |
| Halozyme Inc | 2 | $36 |
| Tolmar, Inc. | 1 | $29 |
| AbbVie | 1 | $25 |
| Travere Therapeutics, Inc. | 1 | $23 |
| Pfizer | 1 | $21 |
| Blue Earth Diagnostics | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Dendreon Pharmaceuticals LLC | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
| Photocure Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTAVIVA$1,576
- UroLift$1,463
- Bulkamid$769
- Axonics$574
- GENERAL ERECTILE DYSFUNCTION$420
- AquaBeam Robotic System$288
- GreenLight XPS$258
- LithoVue$216
- GENERAL - THERAPIES$175
- Nanoknife$148
How this compares
$9,242 in reported general payments places this provider in the 90th percentile of 59 urology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 19 | $262,039 |
| ErleadaApalutamide | 15 | $212,827 |
| MyrbetriqMirabegron | 53 | $52,494 |
| GemtesaVibegron | 43 | $50,247 |
| Tamsulosin Hcl | 484 | $6,562 |
| Solifenacin Succinate | 52 | $3,983 |
| Estradiol | 33 | $3,428 |
| Testosterone | 13 | $2,528 |
| Oxybutynin Chloride ErOxybutynin Chloride | 69 | $2,363 |
| Potassium Citrate ErPotassium Citrate | 30 | $2,284 |
| Finasteride | 156 | $1,956 |
| Testosterone Cypionate | 37 | $1,687 |
| NitrofurantoinNitrofurantoin Macrocrystal | 40 | $1,157 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 39 | $1,066 |
| Dutasteride | 16 | $649 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $53 | $314,53472 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $177 | $50,24743 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 59 urology providers in Maine.
Other urology in Rockport
- Sara ValenteRockport$3K
- Lindsey KerrRockport$2K
- Elizabeth AlbertsonRockport$877
- Marshall HallRockport$738
- Lars EllisonRockport$395
- Griffith BatstoneFarmington$123K
- David SobelPortland$58K
- Marc HodroffPortland$17K
- Evan DunnLewiston$9K
- Christopher HenryLewiston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.